Latest Period
Q2 2026
Security Snapshot
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) Institutional Ownership
CUSIP: 558868105
13F Institutional Holders and Ownership History from Q2 2016 to Q2 2026
Institutions Reporting
410
Shares (Excl. Options)
23,569,318
Price
$536.95
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- MDGL on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 23,569,318
- Total 13F value
- $12,649,496,579
- Portfolio coverage rank
- 0.01%
- Share change
- -92,189
- Value change
- -$46,702,193
- Number of holders
- 410
- Shares outstanding
- 23,203,174
- SEC-reported price per share
- $544.51
- Insider filing price
- $544.51
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock is tracked under CUSIP 558868105.
- 410 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 375 to 410 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $12,441,824,469 to $12,649,496,579.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 410 institutions filings for Q2 2026.
Security key
558868105
Latest holder period
Q2 2026
13F holders
410
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
MDGL full holder history
MADRIGAL PHARMACEUTICALS, INC. SEC filings
MADRIGAL PHARMACEUTICALS, INC. company facts
MADRIGAL PHARMACEUTICALS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 558868105:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
MDGL
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 8.8% | +26% | $1,077,715,260 | +$231,599,280 | 2,018,647 | +27% | JANUS HENDERSON GROUP PLC | 31 Mar 2026 |
| FRIEDMAN PAUL A | 7.8% | $982,730,986 | 1,814,831 | Paul A Friedman, M.D. | 10 Dec 2025 | |||
| Taub Rebecca | 7.8% | $982,730,986 | 1,814,831 | Rebecca Taub, M.D. | 10 Dec 2025 | |||
| PAULSON & CO. INC. | 6.1% | -18% | $743,261,329 | -$168,350,516 | 1,392,188 | -18% | PAULSON & CO. INC. | 31 Mar 2026 |
| BlackRock, Inc. | 4.6% | $573,111,435 | 1,067,346 | BlackRock, Inc. | 30 Jun 2026 |
As of 30 Jun 2026, 410 institutional investors reported holding 23,569,318 shares of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL). This represents 102% of the company’s total 23,203,174 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
77%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 9.2% | 2,143,131 | +0.07% | 5.8% | $1,150,754,190 |
| RTW INVESTMENTS, LP | 8.6% | 1,993,687 | 0% | 9.1% | $1,070,510,235 |
| Jupiter Topco LLC | 8.3% | 1,936,099 | 0% | 0.42% | $1,039,649,606 |
| Avoro Capital Advisors LLC | 7.9% | 1,833,333 | +0.83% | 8.8% | $984,408,154 |
| PAULSON & CO. INC. | 5.8% | 1,340,020 | -3.7% | 28% | $719,523,739 |
| BlackRock, Inc. | 5.2% | 1,200,770 | -23% | 0.01% | $644,753,455 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 835,668 | +1% | 0.01% | $448,711,933 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.6% | 825,714 | +19% | 0.08% | $443,367,132 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.4% | 781,731 | -7.1% | 0.02% | $419,750,461 |
| STATE STREET CORP | 2.3% | 527,057 | -14% | 0.01% | $282,995,975 |
| CITADEL ADVISORS LLC | 2.2% | 507,233 | +12% | 0.16% | $272,358,759 |
| UBS Group AG | 1.7% | 401,708 | +241% | 0.03% | $215,697,110 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 374,880 | -18% | 0.01% | $201,342,418 |
| FMR LLC | 1.5% | 356,201 | -30% | 0.01% | $191,262,164 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.4% | 324,123 | -4.8% | 0.52% | $174,037,845 |
| Invesco Ltd. | 1.3% | 301,435 | -8.5% | 0.01% | $161,855,524 |
| ARMISTICE CAPITAL, LLC | 1.2% | 288,000 | +8.9% | 4.3% | $154,641,600 |
| LORD, ABBETT & CO. LLC | 1.2% | 281,500 | +16% | 0.43% | $151,151,000 |
| GOLDMAN SACHS GROUP INC | 1.1% | 246,280 | -11% | 0.01% | $132,240,046 |
| Polar Capital Holdings Plc | 1.1% | 244,274 | -16% | 0.37% | $131,162,924 |
| AMERIPRISE FINANCIAL INC | 1% | 231,205 | +135% | 0.03% | $124,147,079 |
| NORGES BANK | 0.92% | 213,886 | 0.01% | $114,846,088 | |
| Artisan Partners Limited Partnership | 0.91% | 210,205 | +15% | 0.18% | $112,869,575 |
| Pictet Asset Management Holding SA | 0.83% | 192,896 | +3% | 0.1% | $103,486,147 |
| JANE STREET GROUP, LLC | 0.83% | 191,541 | +434% | 0.07% | $102,847,940 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
41
Latest
Q2 2026
Rows shown
1-25 of 41
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 23,569,318 | $12,649,496,579 | -$46,702,193 | $536.95 | 410 |
| 2026 Q1 | 23,773,837 | $12,441,824,469 | +$74,624,268 | $523.47 | 375 |
| 2025 Q4 | 23,561,031 | $13,715,196,817 | +$154,180,477 | $582.34 | 385 |
| 2025 Q3 | 23,389,191 | $10,723,496,299 | -$21,867,277 | $458.66 | 352 |
| 2025 Q2 | 23,552,943 | $7,127,866,991 | -$58,976,553 | $302.64 | 303 |
| 2025 Q1 | 23,618,790 | $7,815,274,189 | +$242,480,129 | $331.23 | 317 |
| 2024 Q4 | 22,954,039 | $7,083,805,672 | +$127,209,746 | $308.57 | 282 |
| 2024 Q3 | 22,638,348 | $4,763,047,302 | -$106,585,037 | $212.22 | 252 |
| 2024 Q2 | 22,870,011 | $6,408,116,328 | +$504,945,812 | $280.16 | 255 |
| 2024 Q1 | 21,107,869 | $5,634,735,243 | +$377,318,349 | $267.04 | 263 |
| 2023 Q4 | 19,769,303 | $4,574,587,850 | +$602,581,939 | $231.38 | 225 |
| 2023 Q3 | 17,386,191 | $2,539,343,386 | +$349,378,221 | $146.04 | 206 |
| 2023 Q2 | 14,848,153 | $3,429,412,203 | +$220,213,706 | $231.00 | 208 |
| 2023 Q1 | 13,867,567 | $3,359,361,973 | +$106,522,160 | $242.26 | 221 |
| 2022 Q4 | 13,305,897 | $3,862,135,682 | +$567,009,121 | $290.25 | 186 |
| 2022 Q3 | 11,751,595 | $763,791,382 | -$25,263,206 | $64.99 | 133 |
| 2022 Q2 | 12,001,137 | $857,568,681 | -$17,315,431 | $71.58 | 130 |
| 2022 Q1 | 12,025,725 | $1,179,864,073 | +$26,264,521 | $98.12 | 132 |
| 2021 Q4 | 11,953,948 | $1,012,214,597 | +$40,893,478 | $84.74 | 139 |
| 2021 Q3 | 10,962,747 | $874,847,601 | -$34,316,604 | $79.79 | 126 |
| 2021 Q2 | 11,229,236 | $1,093,866,439 | -$99,083,348 | $97.41 | 147 |
| 2021 Q1 | 12,210,439 | $1,427,893,568 | -$10,189,929 | $116.97 | 135 |
| 2020 Q4 | 12,273,522 | $1,364,432,852 | +$68,881,092 | $111.17 | 132 |
| 2020 Q3 | 11,637,870 | $1,381,764,563 | +$46,463,709 | $118.73 | 125 |
| 2020 Q2 | 11,257,505 | $1,274,820,026 | +$4,793,161 | $113.25 | 124 |